Anuh Pharma Ltd Financials

Anuh Pharma Ltd Financial Statement

Anuh Pharma Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	169.35	141.63	166.71
Operating Expense	149.07	127.34	144.67
Net Profit	15.04	9.51	15.36
Net Profit Margin	8.88	6.71	9.21
Earning Per Share	3	1.90	3.06
EBIDTA	21.11	14.25	22.27
Effective Tax Rate	19.67	19.03	20.77

Particulars	Sep 2024
Revenue	169.35
Operating Expense	149.07
Net Profit	15.04
Net Profit Margin	8.88
Earning Per Share	3.00
EBIDTA	21.11
Effective Tax Rate	19.67

Anuh Pharma Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	647.00	527.49	486.65
Operating Expenses Annual	571.86	476.21	439.80
Operating Profit Annual	87.25	57.39	52.04
Interest Annual	0.35	0.22	0.96
Depreciation	8.58	9.70	11.96
Net Profit Annual	60.06	36.18	30.56
Tax Annual	18.25	11.29	8.56

Particulars	Mar 2024
Total Revenue Annual	647.00
Operating Expenses Annual	571.86
Operating Profit Annual	87.25
Interest Annual	0.35
Depreciation	8.58
Net Profit Annual	60.06
Tax Annual	18.25

Anuh Pharma Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	1.93	3.80	2.20
Cash Flow from Operations	12.93	53.90	28.86
Cash Flow from Investing	0.92	-43.48	-7.82
Cash Flow from Financing	-8.57	-12.29	-19.45
Cash Flow at the End	7.20	1.93	3.80

Particulars	Mar 2024
Cash Flow at the Beginning	1.93
Cash Flow from Operations	12.93
Cash Flow from Investing	0.92
Cash Flow from Financing	-8.57
Cash Flow at the End	7.20

Anuh Pharma Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	11.92	10.98	10.82
PBIT Margin (%)	10.60	9.14	8.36
PBT Margin (%)	-0.44	-3.05	3.07
Net PROFIT Margin (%)	9.28	6.86	6.28
Return On Networth / Equity (%)	19.49	15.90	15.11
Return On Networth /Employed (%)	25.44	20.82	19.14
Return On Assets (%)	22.28	15.64	14.38
Total Debt / Equity (X)	0.01	0.01	0.04
Asset Turnover Ratio (%)	2.40	2.28	2.29

Particulars	Mar 2024
PBDIT Margin (%)	11.92
PBIT Margin (%)	10.60
PBT Margin (%)	-0.44
Net PROFIT Margin (%)	9.28
Return On Networth / Equity (%)	19.49
Return On Networth /Employed (%)	25.44
Return On Assets (%)	22.28
Total Debt / Equity (X)	0.01
Asset Turnover Ratio (%)	2.40

Anuh Pharma Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	48.95	52.81	61.42
Total Current Assets Annual	336.20	307.61	258.69
Non Current Assets Annual	109.48	97.37	88.49
Total Shareholders Funds Annual	291.22	241.22	213.77
Total Assets Annual	445.68	404.98	347.17

Particulars	Mar 2024
Fixed Assets Annual	48.95
Total Current Assets Annual	336.20
Non Current Assets Annual	109.48
Total Shareholders Funds Annual	291.22
Total Assets Annual	445.68

Anuh Pharma Ltd Earning Calls

No Data Availabe

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, Anuh Pharma Ltd has a market capitalization of 1,230.75 Cr. Value Research classifies it as a Small-Cap company.

Yes, Anuh Pharma Ltd is debt-free with a debt-to-equity ratio of 0.01.

In FY 2023 , Anuh Pharma Ltd recorded a total revenue of approximately 647 Cr marking a significant milestone in the company's financial performance.

Anuh Pharma Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.5% and 0.1% annually, respectively..

Anuh Pharma Ltd's current PE ratio is 20.49.

Anuh Pharma Ltd's ROCE averaged 21.6% from the FY ending March 2022 to 2024, with a median of 19.7%. It peaked at 26.8% in March 2024, reflecting strong capital efficiency over the period..

Anuh Pharma Ltd's latest EBIT is Rs. 78.66 Cr, surpassing the average EBIT of Rs. 55.48 Cr over the 5 years..